
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152543A38AF2E8830543A3005E196022.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="jmirphs">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="JMIR Public Health and Surveillance">
<meta name="citation_title" content="Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial">
<meta name="citation_author" content="Yi Tao">
<meta name="citation_author_institution" content="Phase I Clinical Trial Ward, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China">
<meta name="citation_author" content="Yan Zhang">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_author" content="Bin Peng">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_author" content="Aizhong Zeng">
<meta name="citation_author_institution" content="The First Affiliated Hospital of Chongqing Medical University, Chongqing, China">
<meta name="citation_author" content="Jianghong Dai">
<meta name="citation_author_institution" content="School of Public Health, Xinjiang Medical University, Wulumuqi, China">
<meta name="citation_author" content="Hao Liang">
<meta name="citation_author_institution" content="School of Public Health, Guangxi Medical University, Nanning, China">
<meta name="citation_author" content="Juying Zhang">
<meta name="citation_author_institution" content="West China School of Public Health, Sichuan University, Chengdu, China">
<meta name="citation_author" content="Huarui Shao">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_author_institution" content="Department of Pharmacy, Bishan Hospital of Chongqing Medical University, Yixue Rd 1, Yuzhong District, Chongqing, China">
<meta name="citation_author" content="Shihan Feng">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_author" content="Xiaoni Zhong">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_author" content="Ailong Huang">
<meta name="citation_author_institution" content="School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="e71494">
<meta name="citation_doi" content="10.2196/71494">
<meta name="citation_pmid" content="40834420">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/">
<meta name="description" content="Pre-exposure prophylaxis (PrEP) programs have been implemented in multiple countries. Evidence from clinical trials and cohort studies has proven the safety and effectiveness of PrEP. However, minimizing drug-related adverse effects and cost should ...">
<meta name="og:title" content="Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Pre-exposure prophylaxis (PrEP) programs have been implemented in multiple countries. Evidence from clinical trials and cohort studies has proven the safety and effectiveness of PrEP. However, minimizing drug-related adverse effects and cost should ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12367284">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.2196/71494"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367284%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12367284/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12367284/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-jmirphs.png" alt="JMIR Public Health and Surveillance logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to JMIR Public Health and Surveillance" title="Link to JMIR Public Health and Surveillance" shape="default" href="http://publichealth.jmir.org/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">JMIR Public Health Surveill</button></div>. 2025 Aug 20;11:e71494. doi: <a href="https://doi.org/10.2196/71494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.2196/71494</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22JMIR%20Public%20Health%20Surveill%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22JMIR%20Public%20Health%20Surveill%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22JMIR%20Public%20Health%20Surveill%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22JMIR%20Public%20Health%20Surveill%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Tenofovir to Prevent HIV Infection in Western China: Pragmatic Randomized Controlled Trial</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tao%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yi Tao</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Yi Tao</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>1</sup>Phase I Clinical Trial Ward, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tao%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yi Tao</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yan Zhang</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Yan Zhang</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yan Zhang</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Bin Peng</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Bin Peng</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peng%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Bin Peng</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeng%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Aizhong Zeng</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Aizhong Zeng</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>3</sup>The First Affiliated Hospital of Chongqing Medical University, Chongqing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zeng%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aizhong Zeng</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Jianghong Dai</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Jianghong Dai</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>4</sup>School of Public Health, Xinjiang Medical University, Wulumuqi, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Dai%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jianghong Dai</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Hao Liang</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Hao Liang</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>5</sup>School of Public Health, Guangxi Medical University, Nanning, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hao Liang</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Juying Zhang</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Juying Zhang</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>6</sup>West China School of Public Health, Sichuan University, Chengdu, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juying Zhang</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shao%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Huarui Shao</span></a><div hidden="hidden" id="id8">
<h3>
<span class="name western">Huarui Shao</span>, <span class="degrees">MS</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">
<sup>7</sup>Department of Pharmacy, Bishan Hospital of Chongqing Medical University, Yixue Rd 1, Yuzhong District, Chongqing, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shao%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Huarui Shao</span></a>
</div>
</div>
<sup>2,</sup><sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feng%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Shihan Feng</span></a><div hidden="hidden" id="id9">
<h3>
<span class="name western">Shihan Feng</span>, <span class="degrees">MS</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Feng%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shihan Feng</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Xiaoni Zhong</span></a><div hidden="hidden" id="id10">
<h3>
<span class="name western">Xiaoni Zhong</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhong%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoni Zhong</span></a>
</div>
</div>
<sup>2,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Ailong Huang</span></a><div hidden="hidden" id="id11">
<h3>
<span class="name western">Ailong Huang</span>, <span class="degrees">Prof Dr</span>
</h3>
<div class="p">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Huang%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ailong Huang</span></a>
</div>
</div>
<sup>2,</sup><sup>✉,</sup><sup>*</sup>
</div>
<div class="cg p">Editors: <span class="name western">Amaryllis Mavragani</span>, <span class="name western">Travis Sanchez</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>1</sup>Phase I Clinical Trial Ward, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China</div>
<div id="aff2">
<sup>2</sup>School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469</div>
<div id="aff3">
<sup>3</sup>The First Affiliated Hospital of Chongqing Medical University, Chongqing, China</div>
<div id="aff4">
<sup>4</sup>School of Public Health, Xinjiang Medical University, Wulumuqi, China</div>
<div id="aff5">
<sup>5</sup>School of Public Health, Guangxi Medical University, Nanning, China</div>
<div id="aff6">
<sup>6</sup>West China School of Public Health, Sichuan University, Chengdu, China</div>
<div id="aff7">
<sup>7</sup>Department of Pharmacy, Bishan Hospital of Chongqing Medical University, Yixue Rd 1, Yuzhong District, Chongqing, China</div>
<div class="author-notes p">
<div class="fn" id="equal-contrib1">
<sup>*</sup><p class="display-inline">these authors contributed equally</p>
</div>
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Ailong Huang, Prof Dr, School of Public Health, Chongqing Medical University, Yixue Rd1#, Yuzhong district, Chongqing, 400016, China, 86 13508312469; <span>ahuang@cqmu.edu.cn</span></p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jan 20; Revised 2025 Apr 1; Accepted 2025 Apr 28; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>Copyright © Yi Tao, Yan Zhang, Bin Peng, Aizhong Zeng, Jianghong Dai, Hao Liang, Juying Zhang, Huarui Shao, Shihan Feng, Xiaoni Zhong, Ailong Huang. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org)</div>
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Public Health and Surveillance, is properly cited. The complete bibliographic information, a link to the original publication on <a href="https://publichealth.jmir.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://publichealth.jmir.org</a>, as well as this copyright and license information must be included.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12367284  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40834420/" class="usa-link">40834420</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p>Pre-exposure prophylaxis (PrEP) programs have been implemented in multiple countries. Evidence from clinical trials and cohort studies has proven the safety and effectiveness of PrEP. However, minimizing drug-related adverse effects and cost should be primarily considered in PrEP. Most trials used tenofovir combined with emtricitabine as the intervention; yet, the use of tenofovir disoproxil fumarate (TDF) (ie, Tenofovir) alone has not been thoroughly evaluated. Furthermore, the medication regimen in most trials was used every day, with a few studies proposing an optimal medication regimen for PrEP.</p></section><section id="sec2"><h3 class="pmc_sec_title">Objective</h3>
<p>This study was designed to systematically evaluate the preventive efficacy and safety profile of TDF-based PrEP in the Chinese population. We also aimed to explore medication compliance, changes in sexual behavior, and hazard factors of HIV infection.</p></section><section id="sec3"><h3 class="pmc_sec_title">Methods</h3>
<p>We conducted a pragmatic randomized controlled trial (RCT) to evaluate the effectiveness and safety of TDF for HIV PrEP. Participants were randomly assigned (1:1:1) to a time-driven group (TDF 300 mg administered orally once daily), an event-driven group (TDF 300 mg administered orally 24 to 48 h before sexual activity and 2 hours after sexual activity, not exceeding 300 mg within 24 h), or an untreated control group. The primary outcomes were the effectiveness and safety of TDF during periods of PrEP use. Secondary outcomes focused on the effectiveness of TDF among participants with good compliance during PrEP use. Tertiary outcomes included the risk factors of HIV infection and behavioral changes from PrEP initiation to the last visit. For ethical reasons, all participants received condoms and health education. This study was registered with the Chinese Clinical Trial Registry (ChiCTR-TRC-13003849).</p></section><section id="sec4"><h3 class="pmc_sec_title">Results</h3>
<p>A total of 1914 participants underwent randomization. During the follow-up of 3513.5 person-years from June 2013 to May 2016, HIV seroconversion was observed in 30 persons (2.02 per 100 person-years) in the time-driven group (time-driven vs control group: hazard ratio [HR] 0.93, 95% CI 058‐1.51; <em>P</em>=.78), 35 (1.73 per 100 person-years) in the event-driven group (event-driven group vs control group: HR 0.83, 95% CI 0.52‐1.31; <em>P</em>=.42), and 37 (2.06 per 100 person-years) in the control group. Post hoc analysis showed that participants with good medication compliance reduced their HIV infection risk by 53% (<em>P</em>=.01) and event-driven medication with good compliance reduced the risk by 62% (<em>P</em>=.009). We recorded no severe adverse events during the trial. For tertiary outcomes, low medication compliance, sexual role, no condom use, and more number of sexual partners remained significantly associated with HIV risk.</p></section><section id="sec5"><h3 class="pmc_sec_title">Conclusions</h3>
<p>The TDF-based PrEP is ineffective without good adherence. However, when medication compliance is achieved, event-driven dosing is recommended as an optimal PrEP regimen.</p></section></section><section id="s1"><h2 class="pmc_sec_title">Introduction</h2>
<p>While the global AIDS epidemic remains a persistent public health threat, advancements in antiretroviral therapy and prevention strategies have substantially reduced mortality and improved treatment access, albeit unevenly across regions and populations. In 2023, there were approximately 1.3 million new HIV infections and 630,000 AIDS-related deaths globally, reflecting reductions in both new infections and mortality compared to previous years [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>]. HIV remains a major public health issue in China, with an estimated 570,576 HIV infections between 2005 and 2020, particularly concentrated in western China [<a href="#R2" class="usa-link" aria-describedby="R2">2</a>]. In 2023, data released by China’s National Administration of Disease Control and Prevention and the Chinese Center for Disease Control and Prevention (China CDC) provided a clear overview of the HIV/AIDS epidemic in mainland China. Notably, the provinces of Sichuan, Guangxi, and Chongqing reported the highest HIV infection rates nationwide. Additionally, regions such as Xinjiang, Yunnan, and Guizhou also emerged as high-prevalence areas, with the epidemic primarily concentrated in western China [<a href="#R3" class="usa-link" aria-describedby="R3">3</a>]. In 2023, men who have sex with men (MSM), bisexual individuals, sex workers, and people who inject drugs remained the highest-risk groups for HIV, with sexual transmission accounting for more than 95% of new infections in China [<a href="#R1" class="usa-link" aria-describedby="R1">1</a>,<a href="#R4" class="usa-link" aria-describedby="R4">4</a>]. MSM continue to represent the group with the highest HIV incidence rate globally, with infection rates rising nearly 15-fold from 1.5% in 2006 to 25.6% in 2022 [<a href="#R5" class="usa-link" aria-describedby="R5">5</a>,<a href="#R6" class="usa-link" aria-describedby="R6">6</a>].</p>
<p>In the absence of an effective vaccine, core strategies for AIDS prevention include HIV testing [<a href="#R7" class="usa-link" aria-describedby="R7">7</a>], circumcision [<a href="#R8" class="usa-link" aria-describedby="R8">8</a>], condom use, and health education [<a href="#R9" class="usa-link" aria-describedby="R9">9</a>]. However, these measures alone are insufficient. The introduction of tenofovir-based pre-exposure prophylaxis (PrEP) has revolutionized HIV prevention globally [<a href="#R10" class="usa-link" aria-describedby="R10">10</a>]. PrEP involves taking antiretroviral drugs before potential exposure to HIV. It is now widely available as a biomedical prevention method to reduce the risk of HIV infection. The coformulation of two nucleoside or nucleotide reverse transcriptase inhibitors has proven highly effective as PrEP in various populations worldwide [<a href="#R11" class="usa-link" aria-describedby="R11">11</a>]. The compound tablet emtricitabine (ETC)/tenofovir disoproxil fumarate TDF (Truvada) was licensed by the US Food and Drug Administration in 2012 as the first HIV PrEP drug, with studies showing it can reduce HIV incidence by 44% [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>]. However, PrEP’s effectiveness is closely linked to adherence [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. A notable study has demonstrated that cisgender women consistently adhering to a daily or high-adherence regimen of PrEP using ETC and TDF experienced significantly low HIV incidence [<a href="#R14" class="usa-link" aria-describedby="R14">14</a>]. Regarding the optimal dosing regimen, recent research suggests no significant difference in efficacy between daily and event-driven PrEP regimens [<a href="#R15" class="usa-link" aria-describedby="R15">15</a>,<a href="#R16" class="usa-link" aria-describedby="R16">16</a>]. A study conducted in sub-Saharan Africa indicated that event-driven PrEP regimen provided protection across foreskin tissue, highlighting the need for further clinical evaluation of precoital PrEP, specifically for insertive sex [<a href="#R16" class="usa-link" aria-describedby="R16">16</a>].</p>
<p>Despite substantial investments in HIV prevention over the past decades, this field continues to struggle with inadequate long-term investment strategies and resource disparities [<a href="#R17" class="usa-link" aria-describedby="R17">17</a>]. PrEP has been implemented as a national health program in multiple countries [<a href="#R18" class="usa-link" aria-describedby="R18">18</a>]. Acknowledging its substantial cost, ensuring cost-effectiveness and demonstrating potential efficacy are paramount considerations in the implementation of PrEP [<a href="#R19" class="usa-link" aria-describedby="R19">19-21</a>]. The majority of PrEP studies have focused on coformulation of two nucleoside or nucleotide reverse transcriptase inhibitors [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R21" class="usa-link" aria-describedby="R21">21-23</a>,<a href="#R22" class="usa-link" aria-describedby="R22">undefined</a>,<a href="#R23" class="usa-link" aria-describedby="R23">undefined</a>]. Nevertheless, the exploration of PrEP, particularly the use of TDF monotherapy, remains inconclusive. TDF alone is associated with a lower cost, making it a more accessible option in resource-limited settings where budget constraints are critical [<a href="#R24" class="usa-link" aria-describedby="R24">24</a>]. Additionally, by using TDF alone, the regimen may potentially reduce the incidence of certain side effects such as gastrointestinal discomfort or other FTC-related adverse reactions, which could improve patient adherence and overall quality of life [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>]. If TDF is proven to be both effective and safe, it should be regarded as a pivotal public health intervention.</p>
<p>We designed a randomized controlled trial in western China with the primary objective of assessing the effectiveness and safety of TDF use alone among MSM. Furthermore, we aimed to gain insights into its efficacy and safety when administered with high compliance rates. Additionally, we aimed to delve into identifying the optimal medication regimen, hazard factors contributing to HIV infection, as well as examining changes in sexual behavior patterns.</p></section><section id="s2"><h2 class="pmc_sec_title">Methods</h2>
<section id="s2-1"><h3 class="pmc_sec_title">Study Design</h3>
<p>This trial was a multiprovince, open-label, randomized controlled trial conducted in western China, provinces including Chongqing, SiChuan, GuangXi, and XinJiang.</p></section><section id="s2-2"><h3 class="pmc_sec_title">Participants</h3>
<p>A total of 1500 participants were planned for recruitment at four sites, including Chongqing, Guangxi, Xinjiang, and Sichuan, using a combination of competitive enrollment and snowball sampling methods. By leveraging existing cohorts in each province, researchers streamlined the recruitment process. Eligible participants were MSM aged 18 to 65 years, who reported engaging in sexual activity at least once every two weeks on average and having had at least one sexual encounter with a same-sex partner in the month preceding the trial. Exclusion criteria included participants who were HIV-, HBV-, or HCV-positive; had severe underlying medical conditions; had a history of alcoholism or drug dependence within the past year prior to screening; or had a history of severe allergies.</p></section><section id="s2-3"><h3 class="pmc_sec_title">Ethical Considerations</h3>
<p>This study was conducted in accordance with the principles of the Declaration of Helsinki and ICH-GCP (International Council for Harmonisation Good Clinical Practice guidelines). All volunteers provided written informed consent prior to the start of the study. Participants were informed that study data would be deidentified and their participation was voluntary. They were assured that their information would be used solely for this study, and their questionnaire responses would not affect their careers. The study covered the medical expenses of any drug-related adverse reactions or adverse events. No additional financial compensation was provided to participants beyond the standard study procedures. However, participants assigned to the intervention group received free TDF medication, and all participants had access to free condoms and comprehensive health education. In case of irreversible damage, corresponding economic compensation was provided in accordance with national laws. The trial protocol was approved by the Ethics Committee of Chongqing Medical University and registered with the Chinese Clinical Trial Registry (ChiCTR-TRC-13003849).</p></section><section id="s2-4"><h3 class="pmc_sec_title">Randomization and Masking</h3>
<p>Randomization was performed using a central, computerized system using block randomization, stratified by hospital. Except for questionnaire administrators, neither patients nor other researchers were blinded to group allocation. Participants were randomly assigned in a 1:1:1 ratio to the time-driven group (TDF 300 mg administered orally once daily), the event-driven group (Tenofovir 300 mg administered orally 24‐48 h before and 2 h after sexual activity, not exceeding 300 mg within 24 h), or the untreated control group.</p></section><section id="s2-5"><h3 class="pmc_sec_title">Procedures</h3>
<p>Baseline information encompassing demographic data, medical histories, and sexual behavior patterns was meticulously documented (see <a href="#SAP1" class="usa-link">Multimedia Appendix 1</a>). Comprehensive laboratory assessments, including tests for transfusion-associated infections such as HIV, HBV, and HCV, along with electrocardiograms, were conducted, with all participants undergoing an HIV test on the day of randomization. Interventions were tailored to the standard operating procedures at each study site. Follow-up visits were scheduled at regular intervals of 12 weeks, extending up to 96 weeks, and encompassed a range of evaluations. These included repeat HIV testing, routine laboratory investigations, assessments of medication adherence, inquiries into sexual behavior and sexually transmitted infections (STIs), collection of medication history, and comprehensive physical examinations. Adherence to these follow-up visits was mandatory for all participants.</p></section><section id="s2-6"><h3 class="pmc_sec_title">Outcomes</h3>
<p>The primary outcomes were effectiveness and safety of TDF during individuals’ periods of PrEP use. Secondary outcomes assessed the effectiveness of TDF for participants with good compliance during periods of PrEP use. Tertiary outcomes included the risk factors of HIV infection and behavioral change from PrEP initiation to the last visit.</p></section><section id="s2-7"><h3 class="pmc_sec_title">Statistical Analysis</h3>
<p>Categorical data were presented as numbers (frequencies) and analyzed using 2-tailed <em>χ</em><sup>2</sup> tests or Fisher exact test. Continuous variables were presented as means and SD for normally distributed data and median and IQR for skewed data. Groups were compared using one-way ANOVA or the Kruskal-Wallis test. Overall incidence rates per 100 person-years during the follow-up period were calculated for all adverse drug reactions. The risk of HIV infection was analyzed using Cox proportional hazards models, with hazard ratios, corresponding 95% CIs, and associated <em>P</em> values.</p>
<p>The ‘survcutpoint’ function from the R package <em>survminer</em> was used to determine the cutoff value for medication compliance, which was estimated based on pill counts and self-reports. The optimal critical value for good medication compliance was established by combining data from previous studies [<a href="#R23" class="usa-link" aria-describedby="R23">23</a>]. The Kaplan-Meier method and log-rank tests were used to analyze the incidences of HIV seroconversion and medication compliance rates among the groups. The multiple imputation method was used to address missing data on the number of sexual partners, sexual acts, and condom use, with five imputations conducted.</p>
<p>Statistical analyses were conducted using R software (version 4.2.1; Foundation for Statistical Computing) and Stata software (version 17; StataCorp). A two-sided <em>P</em> value &lt;.05 was considered statistically significant. For comparison between the three groups, the significance level was adjusted using Bonferroni adjustment.</p></section></section><section id="s3"><h2 class="pmc_sec_title">Results</h2>
<p>From June 2013 to May 2016, 2015 participants were enrolled across four sites: Chongqing (n=909), Guangxi (n=251), Xinjiang (n=328), and Sichuan (n=527), among whom 1914 individuals took at least one medication and participated in the study. This cohort was subsequently followed for a total of 3513.5 person-years, with a median follow-up period of 1.5 years per participant (<a href="#F1" class="usa-link">Figure 1</a>). Baseline characteristics were balanced among the three groups: time-driven (n=584; mean 29, SD 8.4 years), event-driven (n=669; mean age of 30 SD 8.4 years), and untreated control group (n=661; mean age of 30.5 SD 9.2 y) (<a href="#T1" class="usa-link">Table 1</a>).</p>
<figure class="fig xbox font-sm" id="F1"><h3 class="obj_head">Figure 1.  Participants flow chart. MSM: men who have sex with other men.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/9d114c0d0fd4/publichealth-v11-e71494-g001.jpg" loading="lazy" height="577" width="756" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><section class="tw xbox font-sm" id="T1"><h3 class="obj_head">Table 1.  Baseline characteristics of participants (N=1914).</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th valign="bottom" rowspan="1" colspan="1">Characteristics</th>
<th valign="bottom" rowspan="1" colspan="1">Time-driven group<br>(n=584)</th>
<th valign="bottom" rowspan="1" colspan="1">Event-driven group<br>(n=669)</th>
<th valign="bottom" rowspan="1" colspan="1">Untreated control group (n=661)</th>
</tr></thead>
<tbody>
<tr>
<td valign="top" rowspan="1" colspan="1">Age (years), median (IQR)</td>
<td align="left" valign="top" rowspan="1" colspan="1">29.02 (8.43)</td>
<td align="left" valign="top" rowspan="1" colspan="1">29.98 (8.38)</td>
<td align="left" valign="top" rowspan="1" colspan="1">30.48 (9.23)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Nationality (n=1913), n (%)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Han</td>
<td align="left" valign="top" rowspan="1" colspan="1">541 (92.80)</td>
<td align="left" valign="top" rowspan="1" colspan="1">617 (92.23)</td>
<td align="left" valign="top" rowspan="1" colspan="1">619 (93.65)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Uygur</td>
<td align="left" valign="top" rowspan="1" colspan="1">3 (0.51)</td>
<td align="left" valign="top" rowspan="1" colspan="1">7 (1.05)</td>
<td align="left" valign="top" rowspan="1" colspan="1">6 (0.91)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Hui</td>
<td align="left" valign="top" rowspan="1" colspan="1">7 (1.20)</td>
<td align="left" valign="top" rowspan="1" colspan="1">10 (1.49)</td>
<td align="left" valign="top" rowspan="1" colspan="1">11 (1.66)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Other</td>
<td align="left" valign="top" rowspan="1" colspan="1">32 (5.49)</td>
<td align="left" valign="top" rowspan="1" colspan="1">35 (5.49)</td>
<td align="left" valign="top" rowspan="1" colspan="1">25 (3.78)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Degree of education (n=1912), n (%)<sup><a href="#T1_FN1" class="usa-link">a</a></sup>
</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> High school and below</td>
<td align="left" valign="top" rowspan="1" colspan="1">225 (38.53)</td>
<td align="left" valign="top" rowspan="1" colspan="1">239 (35.72)</td>
<td align="left" valign="top" rowspan="1" colspan="1">288 (43.57)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Colleges</td>
<td align="left" valign="top" rowspan="1" colspan="1">142 (24.36)</td>
<td align="left" valign="top" rowspan="1" colspan="1">155 (23.20)</td>
<td align="left" valign="top" rowspan="1" colspan="1">168 (25.42)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Bachelor’s degree or above</td>
<td align="left" valign="top" rowspan="1" colspan="1">216 (37.05)</td>
<td align="left" valign="top" rowspan="1" colspan="1">274 (41.02)</td>
<td align="left" valign="top" rowspan="1" colspan="1">205 (31.01)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Registered residence (n=1908), n (%)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Urban</td>
<td align="left" valign="top" rowspan="1" colspan="1">415 (71.31)</td>
<td align="left" valign="top" rowspan="1" colspan="1">497 (74.40)</td>
<td align="left" valign="top" rowspan="1" colspan="1">456 (69.30)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Rural</td>
<td align="left" valign="top" rowspan="1" colspan="1">167 (28.69)</td>
<td align="left" valign="top" rowspan="1" colspan="1">171 (25.60)</td>
<td align="left" valign="top" rowspan="1" colspan="1">202 (30.70)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Marriage, n (%)<sup><a href="#T1_FN1" class="usa-link">a</a></sup>
</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Unmarried</td>
<td align="left" valign="top" rowspan="1" colspan="1">458 (78.42)</td>
<td align="left" valign="top" rowspan="1" colspan="1">491 (73.39)</td>
<td align="left" valign="top" rowspan="1" colspan="1">478 (72.31)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Married</td>
<td align="left" valign="top" rowspan="1" colspan="1">87 (14.90)</td>
<td align="left" valign="top" rowspan="1" colspan="1">110 (16.44)</td>
<td align="left" valign="top" rowspan="1" colspan="1">130 (19.67)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Other</td>
<td align="left" valign="top" rowspan="1" colspan="1">39 (6.68)</td>
<td align="left" valign="top" rowspan="1" colspan="1">68 (10.16)</td>
<td align="left" valign="top" rowspan="1" colspan="1">53 (8.02)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Occupation (n=1906)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Public institutions and enterprises</td>
<td align="left" valign="top" rowspan="1" colspan="1">65 (11.21)</td>
<td align="left" valign="top" rowspan="1" colspan="1">86 (12.89)</td>
<td align="left" valign="top" rowspan="1" colspan="1">73 (11.08)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Professional work</td>
<td align="left" valign="top" rowspan="1" colspan="1">128 (22.07)</td>
<td align="left" valign="top" rowspan="1" colspan="1">182 (27.29)</td>
<td align="left" valign="top" rowspan="1" colspan="1">142 (21.55)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Physical work</td>
<td align="left" valign="top" rowspan="1" colspan="1">30 (5.17)</td>
<td align="left" valign="top" rowspan="1" colspan="1">43 (6.45)</td>
<td align="left" valign="top" rowspan="1" colspan="1">49 (7.44)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Commercial work</td>
<td align="left" valign="top" rowspan="1" colspan="1">82 (14.14)</td>
<td align="left" valign="top" rowspan="1" colspan="1">89 (13.34)</td>
<td align="left" valign="top" rowspan="1" colspan="1">86 (13.05)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Service Industry</td>
<td align="left" valign="top" rowspan="1" colspan="1">89 (15.34)</td>
<td align="left" valign="top" rowspan="1" colspan="1">79 (11.84)</td>
<td align="left" valign="top" rowspan="1" colspan="1">95 (14.42)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Farmers and herdsmen</td>
<td align="left" valign="top" rowspan="1" colspan="1">3 (0.52)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2 (0.30)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3 (0.46)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Students</td>
<td align="left" valign="top" rowspan="1" colspan="1">91 (15.58)</td>
<td align="left" valign="top" rowspan="1" colspan="1">94 (14.05)</td>
<td align="left" valign="top" rowspan="1" colspan="1">83 (12.59)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Unemployed</td>
<td align="left" valign="top" rowspan="1" colspan="1">54 (9.25)</td>
<td align="left" valign="top" rowspan="1" colspan="1">49 (7.32)</td>
<td align="left" valign="top" rowspan="1" colspan="1">76 (11.53)</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Other</td>
<td align="left" valign="top" rowspan="1" colspan="1">38 (6.51)</td>
<td align="left" valign="top" rowspan="1" colspan="1">43 (6.43)</td>
<td align="left" valign="top" rowspan="1" colspan="1">52 (7.89)</td>
</tr>
<tr><td valign="top" colspan="4" rowspan="1">Monthly disposable income (Chinese Yuan)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> ≤3000</td>
<td align="left" valign="top" rowspan="1" colspan="1">309 (52.91)</td>
<td align="left" valign="top" rowspan="1" colspan="1">326 (48.73)</td>
<td align="left" valign="top" rowspan="1" colspan="1">366 (56.22)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 3000‐5000</td>
<td align="left" valign="top" rowspan="1" colspan="1">192 (32.88)</td>
<td align="left" valign="top" rowspan="1" colspan="1">248 (37.07)</td>
<td align="left" valign="top" rowspan="1" colspan="1">212 (32.57)</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≥5000</td>
<td align="left" valign="top" rowspan="1" colspan="1">75 (12.84)</td>
<td align="left" valign="top" rowspan="1" colspan="1">88 (13.15)</td>
<td align="left" valign="top" rowspan="1" colspan="1">73 (11.21)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="T1_FN1">
<sup>a</sup><p class="display-inline">Statistical differences among the three groups.</p>
</div></div></section><section id="s3-1"><h3 class="pmc_sec_title">Primary Outcomes</h3>
<p>HIV seroconversion was observed in 30 participants (incidence rate [IR] 5.1%, 2.02 per 100 person-years) in the time-driven group (time-driven group vs untreated control group, hazard ratio [HR] 0.93; 95% CI, 0.58‐1.51, <em>P</em>=.78), 35 participants in the event-driven group (IR 5.2%, 1.73 per 100 person-years) (event-driven group vs untreated control group: HR 0.83; 95% CI, 0.52‐1.31, <em>P</em>=.42) and 37 participants in the untreated control group (IR 5.6%, 2.06 per 100 person-years) (<a href="#F2" class="usa-link">Figure 2</a>).</p>
<figure class="fig xbox font-sm" id="F2"><h4 class="obj_head">Figure 2. Kaplan-Meier estimates of HIV seroconversion in the time-driven, event-driven, and untreated control groups.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/51e590b86d68/publichealth-v11-e71494-g002.jpg" loading="lazy" height="461" width="752" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>No severe adverse events were reported. For dosing as a precautionary medication, laboratory test indicators exceeding 1.5 to 2 times the upper limit of the normal range were regarded as abnormal. The incidence of composite drug-related adverse events was 39.33%. Rates of abnormality in laboratory indicators in the time-driven and event-driven groups were 37.9% and 37.7%, respectively. The toped three abnormalities were elevated triglycerides (8.2%), alanine aminotransferase (ALT; 5.0%), and urine protein (5.0%). Symptomatic adverse events were reported in 1.5% and 1.6% of participants, respectively, with the top-ranked three abnormalities being diarrhea, vomiting, and nausea (<a href="#F3" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="F3"><h4 class="obj_head">Figure 3. Adverse events in time-driven group and event-driven groups. ALT: Alanine Aminotransferase; AST: Aspartate Aminotransferase; BUN: Blood Urea Nitrogen; TBiL: Total Bilirubin; DBiL: Direct Bilirubin (also known as Conjugated Bilirubin); ALB: Albumin; Cr: Creatinine; FPG: Fasting Plasma Glucose; TC: Total Cholesterol; CK: Creatine Kinase; AMY: Amylase; Hb: Hemoglobin; WBC: White Blood Cell Count; GRAN: Granulocyte Percentage; LYM: Lymphocyte Percentage; PLT: Platelet Count; U-GLU: Urine Glucose; U-WBC: Urine White Blood Cells; U-RBC: Urine Red Blood Cells; U-PRO: Urine Protein; U-BIL: Urine Bilirubin.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/5ed4006ac3d3/publichealth-v11-e71494-g003.jpg" loading="lazy" height="800" width="676" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/F3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The cohort was followed for 3513.5 person-years with a variable duration of visits (median 1.5 y). HIV seroconversion was observed in 30 participants (HR, 5.1%, 2.02 per 100 person-years) in the time-driven group (time-driven group vs blank group, HR, 0.93; 95% CI, 0.58‐1.51, <em>P</em>=.78), 35 (5.2%, 1.73 per 100 person-years) in the event-driven group (event-driven group vs blank group, hazard ratio, 0.83; 95% CI, 0.52‐1.31, <em>P</em>=.420) and 37 (5.6%, 2.06 per 100 person-years) in the blank group.</p></section><section id="s3-2"><h3 class="pmc_sec_title">Secondary Outcome</h3>
<p>The overall average medication compliance rate was 68.4%; event-driven group (77.0%) revealed higher adherence than in the time-event group (57.4%). The cutoff value calculated by <em>R</em> software was 40%, double the cutoff value and integrated with previous studies, we defined the optimal critical value of good medication compliance as 80% [<a href="#R25" class="usa-link" aria-describedby="R25">25</a>]. Kaplan-Meier estimates showed that participants with good medication compliance had a 53% reduced hazard of HIV infection compared with the untreated group (<em>P=</em>.01) (<a href="#F4" class="usa-link">Figure 4</a>). Additionally, time-driven PrEP reduced HIV infection hazard by 62% among those with ≥80% compliance (<em>P＜</em>.01) (<a href="#F5" class="usa-link">Figure 5</a>).</p>
<figure class="fig xbox font-sm" id="F4"><h4 class="obj_head">Figure 4. Kaplan-Meier estimates of HIV seroconversion for good medication compliance, poor compliance, and untreated control.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/5992bc9ee8f8/publichealth-v11-e71494-g004.jpg" loading="lazy" height="482" width="770" alt="Figure 4."></a></p>
<div class="p text-right font-secondary"><a href="figure/F4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><figure class="fig xbox font-sm" id="F5"><h4 class="obj_head">Figure 5. Kaplan-Meier estimates for HIV seroconversion in time-driven group, event-driven group, and untreated control groups with medication compliance rate ≥80%.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/d81ce67134d1/publichealth-v11-e71494-g005.jpg" loading="lazy" height="506" width="797" alt="Figure 5."></a></p>
<div class="p text-right font-secondary"><a href="figure/F5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>After adjustment for medication compliance rate ≥ 80%, good medication compliance reduced the hazard of HIV infection by 53% (<em>P</em>=.01).</p>
<p>Similarly, event-driven dosing reduced the hazard by 62% (<em>P</em>=.01).</p></section><section id="s3-3"><h3 class="pmc_sec_title">Tertiary Outcome</h3>
<p>Both unadjusted and adjusted HRs for factors associated with HIV infection during follow-up are shown in <a href="#T2" class="usa-link">Table 2</a>. Bivariable Cox regression analyses identified several characteristics significantly associated with HIV infection, including medication compliance, residence, sex role, condom use, number of sexual partners, casual sexual behavior, STI diagnosis, commercial sex, and drug addiction. In the multivariable model, medication compliance, sex role, condom use, and number of sex partners remained significantly associated with HIV risk (<a href="#T2" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="T2"><h4 class="obj_head">Table 2. Unadjusted and adjusted hazard ratios for factors associated with HIV diagnosis among participants during follow-up n=1914. Note: 1. Sex role, “0” represents a receptive/bottom role; “1” represents a insertive/top role; “0.5” represents a versatile/switch role. 2. “Drug” refers to recreational substances (eg, alcohol, cannabis, ecstasy, poppers).</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th valign="bottom" rowspan="1" colspan="1">Characteristics</th>
<th valign="bottom" rowspan="1" colspan="1">Number of HIV seroconversion (%)</th>
<th colspan="2" valign="bottom" rowspan="1">Bivariable analysis</th>
<th colspan="2" valign="bottom" rowspan="1">Multivariable analysis</th>
</tr>
<tr>
<th valign="bottom" rowspan="1" colspan="1">Unadjusted hazard ratio (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">
<em>P</em> value</th>
<th valign="bottom" rowspan="1" colspan="1">Adjusted hazard ratio (95% CI)</th>
<th valign="bottom" rowspan="1" colspan="1">
<em>P</em> value</th>
</tr>
</thead>
<tbody>
<tr><td valign="top" colspan="6" rowspan="1">Group</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Untreated control group (n=661)</td>
<td align="left" valign="top" rowspan="1" colspan="1">37 (5.60)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">—<a href="#T2_FN2" class="usa-link"><sup>b</sup></a> </td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Time-driven group (n=584)</td>
<td align="left" valign="top" rowspan="1" colspan="1">30 (5.14)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.93 (0.58‐1.51)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.78</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Event-driven group (n=669)</td>
<td align="left" valign="top" rowspan="1" colspan="1">35 (5.23)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.83 (0.52‐1.31)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.42</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" colspan="3" rowspan="1">Dosing</td>
<td align="left" valign="top" rowspan="1" colspan="1">.51 </td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> No (n=661)</td>
<td align="left" valign="top" rowspan="1" colspan="1">37 (5.60)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Yes (n=1253)</td>
<td align="left" valign="top" rowspan="1" colspan="1">65 (5.19)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.87 (0.58‐1.31)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" colspan="3" rowspan="1">PrEP compliance</td>
<td align="left" valign="top" rowspan="1" colspan="1">.001 </td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">.001 </td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≥80% (n=434)</td>
<td align="left" valign="top" rowspan="1" colspan="1">16 (3.69)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> &lt;80% (n=509)</td>
<td align="left" valign="top" rowspan="1" colspan="1">49 (9.63)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.55 (1.44‐4.51)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">2.97 (1.59‐5.54)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Age</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">0.98 (0.95‐1.00)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.07</td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Residence</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">.04 </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">.07 </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Urban (n=1368)</td>
<td align="left" valign="top" rowspan="1" colspan="1">65 (4.75)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Rural (n=540)</td>
<td align="left" valign="top" rowspan="1" colspan="1">37 (6.85)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.66 (0.44‐0.98)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">1.67 (0.95‐2.93)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr><td valign="top" colspan="6" rowspan="1">Education</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> High school and below (n=236)</td>
<td align="left" valign="top" rowspan="1" colspan="1">14 (5.93)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> College degree (n=981)</td>
<td align="left" valign="top" rowspan="1" colspan="1">60 (6.12)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.07 (0.60‐1.92)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.82</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Bachelor’s and above (n=695)</td>
<td align="left" valign="top" rowspan="1" colspan="1">28 (4.03)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.71 (0.37‐1.35)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.30</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr><td valign="top" colspan="6" rowspan="1">Career</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Civil service institutions (n=109)</td>
<td align="left" valign="top" rowspan="1" colspan="1">4 (3.67)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Corporation (n=824)</td>
<td align="left" valign="top" rowspan="1" colspan="1">39 (4.73)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.53 (0.18‐1.56)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.25</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Service industry (n=263)</td>
<td align="left" valign="top" rowspan="1" colspan="1">18 (6.84)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.68 (0.39‐1.19)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.18</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Physical labor (n=263)</td>
<td align="left" valign="top" rowspan="1" colspan="1">18 (6.84)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.96 (0.50‐1.85)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.91</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" colspan="3" rowspan="1">Marriage</td>
<td align="left" valign="top" rowspan="1" colspan="1">.77 </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Unmarried (n=1587)</td>
<td align="left" valign="top" rowspan="1" colspan="1">83 (5.23)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Married (n=327)</td>
<td align="left" valign="top" rowspan="1" colspan="1">19 (5.81)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.04 (0.78‐1.40)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr><td valign="top" colspan="6" rowspan="1">Monthly income</td></tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≤3000 (n=1001)</td>
<td align="left" valign="top" rowspan="1" colspan="1">58 (5.79)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> 3000-5000 (n=652)</td>
<td align="left" valign="top" rowspan="1" colspan="1">34 (5.21)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.95 (0.63‐1.46)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.83</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> ≥5000 (n=236)</td>
<td align="left" valign="top" rowspan="1" colspan="1">9 (3.81)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.79 (0.39‐1.60)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.51</td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
</tr>
<tr><td valign="top" colspan="6" rowspan="1">Sexual roles</td></tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 1 (n=923)</td>
<td align="left" valign="top" rowspan="1" colspan="1">43 (4.66)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">—</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1">— </td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 0 (n=485)</td>
<td align="left" valign="top" rowspan="1" colspan="1">38 (7.84)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.72 (1.11‐2.66)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.02</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.22 (1.25‐3.95)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.007</td>
</tr>
<tr>
<td valign="top" align="center" rowspan="1" colspan="1"> 0.5 (n=498)</td>
<td align="left" valign="top" rowspan="1" colspan="1">21 (4.22)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.94 (0.56‐1.59)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.83</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.82 (0.38‐1.77)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.61</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Condom use in last 6 months (%)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">.02</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.02 </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Always (n=982)</td>
<td align="left" valign="top" rowspan="1" colspan="1">45 (4.58)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Sometimes or never (n=757)</td>
<td align="left" valign="top" rowspan="1" colspan="1">43 (6.74)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1.65 (1.10‐2.46)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">1.88 (1.11‐3.20)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr><td valign="top" colspan="6" rowspan="1">Sex partners in 6 months (%)</td></tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> 1-5 (n=1729)</td>
<td align="left" valign="top" rowspan="1" colspan="1">82 (4.74)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> &gt;5 (n=116)</td>
<td align="left" valign="top" rowspan="1" colspan="1">18 (15.52)</td>
<td align="left" valign="top" rowspan="1" colspan="1">3.54 (2.12‐5.90)</td>
<td align="left" valign="top" rowspan="1" colspan="1">&lt;.001</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.60 (1.28‐5.30)</td>
<td align="left" valign="top" rowspan="1" colspan="1">.008</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">STI<a href="#T2_FN1" class="usa-link"><sup>a</sup></a> diagnosis</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.005</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.15</td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Ever diagnosed with STI (n=156)</td>
<td align="left" valign="top" rowspan="1" colspan="1">17 (10.90)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Never diagnosed with STI (n=1753)</td>
<td align="left" valign="top" rowspan="1" colspan="1">84 (4.79)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.47 (0.28‐0.79)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">0.56 (0.26‐1.24)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Commercial sexual behavior</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.005 </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.06 </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Yes (n=107)</td>
<td align="left" valign="top" rowspan="1" colspan="1">12 (11.21)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> No (n=1801)</td>
<td align="left" valign="top" rowspan="1" colspan="1">89 (4.94)</td>
<td align="left" valign="top" rowspan="1" colspan="1">0.42 (0.23‐0.77)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">0.44 (0.18‐1.04)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1">Drug contacts</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.05 </td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">.31 </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Never contacted with drugs (n=1830)</td>
<td align="left" valign="top" rowspan="1" colspan="1">96 (5.25)</td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
<td align="left" valign="top" rowspan="1" colspan="1">1 (Reference)</td>
<td align="left" valign="top" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td valign="top" rowspan="1" colspan="1"> Ever contacted with drugs (n=54)</td>
<td align="left" valign="top" rowspan="1" colspan="1">5 (9.26)</td>
<td align="left" valign="top" rowspan="1" colspan="1">2.46 (1.00‐6.07)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
<td align="left" valign="top" rowspan="1" colspan="1">1.86 (0.56‐6.18)</td>
<td align="left" valign="top" rowspan="1" colspan="1"></td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/T2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="T2_FN1">
<sup>a</sup><p class="display-inline">STI: sexually transmitted infection.</p>
</div>
<div class="fn" id="T2_FN2">
<sup>b</sup><p class="display-inline">Not applicable.</p>
</div>
</div></section><p>Regarding shifts in sexual behaviors, the number of sexual partners exhibited a fluctuating pattern, initially decreasing across all groups when compared to the baseline, but subsequently increased later during follow-up. Participants in the time-driven group reported the highest number of sexual acts, followed by the event-driven and untreated control groups. However, a positive correlation emerged between condom use and the follow-up period. Notably, participants in the untreated control group reported the highest frequency of condom use, followed by the time-driven and event-driven groups reporting the lowest levels (<a href="#F6" class="usa-link">Figure 6</a>).</p>
<figure class="fig xbox font-sm" id="F6"><h4 class="obj_head">Figure 6. Changes in sexual practice of MSM during the follow-up. MSM: men who have sex with men.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12367284_publichealth-v11-e71494-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70db/12367284/ac3388d7572a/publichealth-v11-e71494-g006.jpg" loading="lazy" height="142" width="688" alt="Figure 6."></a></p>
<div class="p text-right font-secondary"><a href="figure/F6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure><p>The event-driven group exhibits a higher total number of symptom abnormalities (n=33 adverse events) compared to the time-driven group (n=22). Specifically, the number of diarrhea abnormalities was 6 in the time-driven group and 11 in the event-driven group; for vomiting, 1 versus 5; for dizziness, 1 versus 4; and for nausea, 2 versus 3, in the time-driven and event-driven groups, respectively. Conversely, the time-driven group showed a higher count in the "Others" category, with 10 abnormalities compared to 5 in the event-driven group.</p></section></section><section id="s4"><h2 class="pmc_sec_title">Discussion</h2>
<section id="s4-1"><h3 class="pmc_sec_title">Principal Findings</h3>
<p>Although the data from this study are nearly a decade old, our findings remain highly relevant in the field of PrEP, particularly in China. To our knowledge, this study represents the most extensive PrEP trial conducted in China to date, characterized by its comprehensive scope and substantial sample size, which collectively enhance the robustness and generalizability of our findings. Through rigorous statistical analysis, we evaluated the feasibility, efficacy, and safety of TDF as a standalone PrEP intervention. Our analysis demonstrates that while TDF administered as standalone PrEP is safe, it does not provide significant protection against HIV. However, under conditions of high adherence (≥80% dosing compliance), TDF exhibits a substantial 53% reduction in HIV infection risk, underscoring the critical role of medication consistency in achieving prophylactic efficacy. Furthermore, we advocate for an event-driven medication regimen to balance safety with cost-effectiveness. Our analysis also highlights several risk factors for HIV acquisition, including poor PrEP compliance, receptive sexual role, occasional condom use, and having multiple sex partners (&gt;5). Notably, contrary to early studies, we observed sexual behavioral disinhibition during the follow-up period, further underscoring the complexity of sexual practices and the need for targeted interventions [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>,<a href="#R26" class="usa-link" aria-describedby="R26">26</a>].</p>
<p>The combination of tenofovir and emtricitabine has demonstrated efficacy in preventing HIV acquisition, which was licensed as PrEP in China in August 2020 [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>]. However, due to the high incidence of adverse drug reactions observed in pilot trials and the barrier of expensive drug prices, we ultimately decided to explore the efficacy and safety of using TDF alone as PrEP. Initiating treatment with a foundational drug was pivotal in mitigating the potential risk of HIV drug resistance associated with PrEP utilization. While individuals engaging in behaviors associated with heightened HIV risk may experience disparities in certain health indicators, epidemiological data suggest this population often demonstrates baseline physiological resilience. This relative health stability, coupled with tenofovir’s well-documented safety profile in diverse cohorts, supports its consideration as a sustainable PrEP option for long-term use, particularly when integrated with adherence support systems. Furthermore, given the good medication compliance observed in pilot trials and the relatively easier recruitment of individuals, MSM were chosen as participants for the pivotal trials.</p>
<p>The HIV incidence reported in our study was notably lower than that observed in previous investigations [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R12" class="usa-link" aria-describedby="R12">12</a>], which may be attributable to the comprehensive health education and consistent condom distribution implemented at every study visit. No statistically significant difference emerged between the medication groups and the untreated control group. However, tenofovir monotherapy was found to confer an additional 53% reduction in the hazard of HIV infection. Furthermore, when medication was administered on an event-driven basis, this protective effect was even more pronounced, with a 62% reduction in the hazard of HIV infection. These findings highlight the importance of adherence and tailored dosing schedules in maximizing the preventative potential of tenofovir as PrEP [<a href="#R27" class="usa-link" aria-describedby="R27">27</a>,<a href="#R28" class="usa-link" aria-describedby="R28">28</a>].</p>
<p>After comprehensive multivariable adjustment, only poor PrEP compliance was significantly related to sexual practices among the five major hazard components (HR &gt; 2). Adherence to daily PrEP dosing was influenced by several factors, notably diminished motivation when individuals regarded PrEP as a situational preventive tool rather than an integral part of their routine health management. This perception often undermines consistent pill-taking, as prophylactic measures are frequently viewed as temporary responses to risk rather than sustained health practices [<a href="#R29" class="usa-link" aria-describedby="R29">29</a>]. Echoing earlier findings from the pioneering PrEP clinical trials and the landmark PROUD study, our results highlight the paramount importance of high medication adherence in maximizing PrEP’s effectiveness in preventing HIV seroconversion [<a href="#R12" class="usa-link" aria-describedby="R12">12</a>].</p>
<p>While sexual practices are well-established risk factors for HIV infection [<a href="#R30" class="usa-link" aria-describedby="R30">30</a>], our study observed a phenomenon of sexual behavioral disinhibition during the follow-up period. This aligns with a systematic review of 17 open-label PrEP studies, which consistently reported a rise in sexual practice and bacterial STIs among PrEP users [<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. HIV prevention measures encompass HIV testing, the free distribution of condoms, health education, and HIV counseling. After initiating a PrEP scheme, there may be a reduction in condom use and the frequency of HIV testing, or an increase in sexually transmitted infections (STIs). The medication group’s slightly disinhibited behavior could be attributed to a multifaceted interplay of psychological, behavioral, and biological factors. First, risk compensation psychology suggests that individuals may subconsciously adjust their behavior in response to perceived reductions in HIV risk, a cognitive bias where decreased vigilance towards HIV acquisition risks aligns with Prospect Theory—perceived risk reduction increases tolerance for riskier choices [<a href="#R32" class="usa-link" aria-describedby="R32">32</a>]. Second, miscalibration of PrEP efficacy may play a role, as overestimation of PrEP’s protective effects (eg, ignoring the need for adherence) or underestimating the persistence of other STIs can fuel riskier practices; notably, a study in JAMA Network Open found that 30% of PrEP users overestimated its efficacy against STIs [<a href="#R13" class="usa-link" aria-describedby="R13">13</a>]. Third, social norms and sexual scripting within MSM communities may inadvertently normalize riskier behaviors if narratives around “treatment as prevention” (TasP) or “undetectable=untransmittable” are decoupled from broader sexual health education [<a href="#R31" class="usa-link" aria-describedby="R31">31</a>]. Finally, biological factors might contribute, as reduced anxiety about HIV acquisition could heighten sexual arousal and motivation, indirectly elevating behavioral frequency or intensity, even though PrEP itself does not increase libido[加5]. Together, these elements create a complex dynamic that may underpin the observed behavioral disinhibition in the medication group. This indicates the need for comprehensive risk reduction counseling and ongoing education to mitigate potential behavioral changes that may undermine the protective benefits of PrEP. Experience from the USA, UK, and Australia suggests that to address these issues, it is important to enhance STI testing, establish a robust surveillance system, and base prescriptions on both HIV and STI test results [<a href="#R4" class="usa-link" aria-describedby="R4">4</a>,<a href="#R6" class="usa-link" aria-describedby="R6">6</a>].</p>
<p>Implementing PrEP as a nationwide program is imperative, given the compelling evidence that targeting high-risk individuals with PrEP is not only effective but also cost-efficient [<a href="#R19" class="usa-link" aria-describedby="R19">19</a>]. While the adoption of PrEP holds significant promise, it’s crucial to acknowledge a potential drawback: the development of long-term “tolerance,” which could potentially narrow down treatment avenues in the event of an acute HIV infection [<a href="#R33" class="usa-link" aria-describedby="R33">33</a>]. As a fundamental antiviral, tenofovir stands out for its ability to circumvent drug resistance concerns that often complicate treatment regimens. Furthermore, its cost-effectiveness is a significant advantage, alleviating financial burdens for both governmental bodies and individual patients alike. By embracing tenofovir-based PrEP, we can forge a path towards a more accessible and sustainable approach to HIV prevention. An event-driven medication regimen was recommended for PrEP. The IPERGAY trial demonstrated that an event-driven regimen of tenofovir disoproxil fumarate-emtricitabine reduced incidence of HIV infection by 86% [<a href="#R34" class="usa-link" aria-describedby="R34">34</a>]. Pharmacokinetically, tenofovir reaches its maximum concentration (T<sub>max</sub>) in approximately 1 hour and has a half-life (T<sub>1/2</sub>) of around 18 hours. This event-driven regimen maintains drug concentration at a high level in vivo. Additionally, medication compliance was higher with the event-driven regimen compared to daily dosing. In the event-driven group, the median number of pills used was four per month, compared to an average of sixteen pills reported in the IPERGAY trial for event-driven use, making it significantly less costly than daily medication.</p>
<p>The study has several limitations. First, the absence of a placebo and blinding may introduce bias in the safety assessment, as participants in the time-event group were unwilling to take the medication daily [<a href="#R34" class="usa-link" aria-describedby="R34">34</a>]. The use of a placebo or blinding could lead to unblinding, potentially underestimating compliance. Second, to closely mimic real-world conditions, no additional interventions were implemented to maintain the cohort or improve medication compliance during the trial, resulting in a high drop-out rate and poor adherence. The reliance on self-reported adherence and pill counts may also introduce bias, as these methods can be subjective and prone to overestimation. Finally, while the participants in this study may not represent all MSM in China, the large sample size helped mitigate this concern to some extent [<a href="#R35" class="usa-link" aria-describedby="R35">35</a>].</p></section><section id="s4-2"><h3 class="pmc_sec_title">Conclusion</h3>
<p>In conclusion, the TDF is ineffective without good adherence. When reliable medication compliance is attainable, event-driven dosing emerges as a highly recommended and effective PrEP strategy. These findings resonate profoundly with the practical challenges and opportunities within China, compellingly underscoring the critical urgency of integrating PrEP into national healthcare policies. By prioritizing and implementing such policies, we can fortify our defenses against the spread of HIV, thereby safeguarding the health and well-being of all citizens and fostering a more resilient public health infrastructure.</p></section></section><section id="s5"><h2 class="pmc_sec_title">Supplementary material</h2>
<section class="sm xbox font-sm" id="SAP1"><div class="caption p"><span>Multimedia Appendix 1. Study questionnaire.</span></div>
<div class="media p" id="d67e1544">
<div class="caption">
<a href="/articles/instance/12367284/bin/publichealth-v11-e71494-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">publichealth-v11-e71494-s001.docx</a><sup> (80KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71494</div>
</div></section><section class="sm xbox font-sm" id="SCHL1"><div class="caption p"><span>Checklist 1. CONSORT checklist.</span></div>
<div class="media p" id="d67e1551">
<div class="caption">
<a href="/articles/instance/12367284/bin/publichealth-v11-e71494-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">publichealth-v11-e71494-s002.pdf</a><sup> (214.1KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71494</div>
</div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>This study was funded by The National Major Science and Technology Project (AIDS and hepatitis, and other major infectious disease control and prevention) (2008ZX10001-016).</p>
<p>ALH was awarded a National Major Science and Technology project (AIDS and hepatitis, and other major infectious disease control and prevention) to support the implementing of this study; he is dedicated to infectious diseases research for two decades. We thank the participants and the dedication of the team members.</p>
<p>The funder of the study had no role in study design, data collection, data analysis, data interpretation, and writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.</p>
<p>Generative AI was not used in any portion of the manuscript writing.</p></section><section id="notes1"><h3>Abbreviations</h3>
<dl class="def-list">
<dt>MSM</dt>
<dd><p>men who have sex with men</p></dd>
<dt>PrEP</dt>
<dd><p>pre-exposure prophylaxis</p></dd>
<dt>STI</dt>
<dd><p>sexually transmitted infection</p></dd>
<dt>TDF</dt>
<dd><p>tenofovir disoproxil fumarate</p></dd>
</dl></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn5">
<p><strong>Authors’ Contributions:</strong> Conceptualization: ALH (lead), XNZ (equal)</p>
<p>Data curation: SHF, HRS</p>
<p>Formal analysis: YT (lead), YZ (supporting)</p>
<p>Funding acquisition: ALH</p>
<p>Investigation: YZ, BP, AZZ, JHD, HL, JYZ</p>
<p>Methodology: YT</p>
<p>Project administration: AZZ, JHD, HL, JYZ</p>
<p>Resources: ALH, XNZ</p>
<p>Supervision: ZXN</p>
<p>Validation: YZ, BP</p>
<p>Visualization: ALH (lead), XNZ (equal)</p>
<p>Writing – original draft: YT (lead), BP and YZ (supporting)</p>
<p>Writing – review &amp; editing: ALH, XNZ</p>
</div>
<div class="fn p" id="fn6"><p><strong>Data Availability:</strong> The datasets generated or analyzed during this study are not publicly available due the sensitive nature of the data and the terms outlined in the informed consent, but are available from the corresponding author on reasonable request.</p></div>
<div class="fn p" id="fn7"><p><strong>Conflicts of Interest:</strong> None declared.</p></div>
</div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="R1">
<span class="label">1.</span><cite>Laurence J. “AIDS at a Crossroads:” Highlights from the 2024 UNAIDS Report. AIDS Patient Care STDS. 2024 Nov 1;38(11):493–494. doi: 10.1089/apc.2024.0172. doi.</cite> [<a href="https://doi.org/10.1089/apc.2024.0172" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39166294/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS%20Patient%20Care%20STDS&amp;title=%E2%80%9CAIDS%20at%20a%20Crossroads:%E2%80%9D%20Highlights%20from%20the%202024%20UNAIDS%20Report&amp;author=J%20Laurence&amp;volume=38&amp;issue=11&amp;publication_year=2024&amp;pages=493-494&amp;pmid=39166294&amp;doi=10.1089/apc.2024.0172&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R2">
<span class="label">2.</span><cite>Piri Sahragard H, Karami P. Spatiotemporal analysis of seasonal trends in land surface temperature within the distribution range of Moringa peregrina (Forssk.) in Southern and Southeastern Iran. PLoS ONE. 2024;19(7):e0306642.  doi: 10.1371/journal.pone.0306642. doi.</cite> [<a href="https://doi.org/10.1371/journal.pone.0306642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11271878/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39052565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Spatiotemporal%20analysis%20of%20seasonal%20trends%20in%20land%20surface%20temperature%20within%20the%20distribution%20range%20of%20Moringa%20peregrina%20(Forssk.)%20in%20Southern%20and%20Southeastern%20Iran&amp;author=H%20Piri%20Sahragard&amp;author=P%20Karami&amp;volume=19&amp;issue=7&amp;publication_year=2024&amp;pages=e0306642&amp;pmid=39052565&amp;doi=10.1371/journal.pone.0306642&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R3">
<span class="label">3.</span><cite>Cai C, Tang H, Li D, et al.  Evolution of HIV epidemic and emerging challenges - China, 1989-2023. China CDC Wkly. 2024 Nov 29;6(48):1251–1256. doi: 10.46234/ccdcw2024.251. doi. Medline.</cite> [<a href="https://doi.org/10.46234/ccdcw2024.251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11649988/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39698324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=China%20CDC%20Wkly&amp;title=Evolution%20of%20HIV%20epidemic%20and%20emerging%20challenges%20-%20China,%201989-2023&amp;author=C%20Cai&amp;author=H%20Tang&amp;author=D%20Li&amp;volume=6&amp;issue=48&amp;publication_year=2024&amp;pages=1251-1256&amp;pmid=39698324&amp;doi=10.46234/ccdcw2024.251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R4">
<span class="label">4.</span><cite>McCormack S, Dunn DT, Desai M, et al.  Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016 Jan 2;387(10013):53–60. doi: 10.1016/S0140-6736(15)00056-2. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S0140-6736(15)00056-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4700047/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26364263/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Pre-exposure%20prophylaxis%20to%20prevent%20the%20acquisition%20of%20HIV-1%20infection%20(PROUD):%20effectiveness%20results%20from%20the%20pilot%20phase%20of%20a%20pragmatic%20open-label%20randomised%20trial&amp;author=S%20McCormack&amp;author=DT%20Dunn&amp;author=M%20Desai&amp;volume=387&amp;issue=10013&amp;publication_year=2016&amp;pages=53-60&amp;pmid=26364263&amp;doi=10.1016/S0140-6736(15)00056-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R5">
<span class="label">5.</span><cite>Cohen J, Lo YR, Caceres CF, Klausner JD, Grp WGW. WHO guidelines for HIV/STI prevention and care among MSM and transgender people: implications for policy and practice. Sex Transm Infect. 2013 Nov;89(7):536–538. doi: 10.1136/sextrans-2013-051121. doi. Medline.</cite> [<a href="https://doi.org/10.1136/sextrans-2013-051121" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24123866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sex%20Transm%20Infect&amp;title=WHO%20guidelines%20for%20HIV/STI%20prevention%20and%20care%20among%20MSM%20and%20transgender%20people:%20implications%20for%20policy%20and%20practice&amp;author=J%20Cohen&amp;author=YR%20Lo&amp;author=CF%20Caceres&amp;author=JD%20Klausner&amp;author=WGW%20Grp&amp;volume=89&amp;issue=7&amp;publication_year=2013&amp;pages=536-538&amp;pmid=24123866&amp;doi=10.1136/sextrans-2013-051121&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R6">
<span class="label">6.</span><cite>Traeger MW, Guy R, Asselin J, et al.  Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data. Lancet Infect Dis. 2022 Aug;22(8):1231–1241. doi: 10.1016/S1473-3099(22)00175-X. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S1473-3099(22)00175-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35643090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Infect%20Dis&amp;title=Real-world%20trends%20in%20incidence%20of%20bacterial%20sexually%20transmissible%20infections%20among%20gay%20and%20bisexual%20men%20using%20HIV%20pre-exposure%20prophylaxis%20(PrEP)%20in%20Australia%20following%20nationwide%20PrEP%20implementation:%20an%20analysis%20of%20sentinel%20surveillance%20data&amp;author=MW%20Traeger&amp;author=R%20Guy&amp;author=J%20Asselin&amp;volume=22&amp;issue=8&amp;publication_year=2022&amp;pages=1231-1241&amp;pmid=35643090&amp;doi=10.1016/S1473-3099(22)00175-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R7">
<span class="label">7.</span><cite>Lockman S, Holme MP, Makhema J, et al.  Implementation of universal HIV testing and treatment to reduce HIV incidence in Botswana: the Ya Tsie study. Curr HIV/AIDS Rep. 2020 Oct;17(5):478–486. doi: 10.1007/s11904-020-00523-0. doi. Medline.</cite> [<a href="https://doi.org/10.1007/s11904-020-00523-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32797382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20HIV/AIDS%20Rep&amp;title=Implementation%20of%20universal%20HIV%20testing%20and%20treatment%20to%20reduce%20HIV%20incidence%20in%20Botswana:%20the%20Ya%20Tsie%20study&amp;author=S%20Lockman&amp;author=MP%20Holme&amp;author=J%20Makhema&amp;volume=17&amp;issue=5&amp;publication_year=2020&amp;pages=478-486&amp;pmid=32797382&amp;doi=10.1007/s11904-020-00523-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R8">
<span class="label">8.</span><cite>Weidner W. Re: Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Eur Urol. 2007 Aug;52(2):605–606. doi: 10.1016/j.eururo.2007.04.090. doi.</cite> [<a href="https://doi.org/10.1016/j.eururo.2007.04.090" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17674440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Urol&amp;title=Re:%20Male%20circumcision%20for%20HIV%20prevention%20in%20young%20men%20in%20Kisumu,%20Kenya:%20a%20randomised%20controlled%20trial&amp;author=W%20Weidner&amp;volume=52&amp;issue=2&amp;publication_year=2007&amp;pages=605-606&amp;pmid=17674440&amp;doi=10.1016/j.eururo.2007.04.090&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R9">
<span class="label">9.</span><cite>Faust L, Yaya S. The effect of HIV educational interventions on HIV-related knowledge, condom use, and HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2018 Nov 13;18(1):1254. doi: 10.1186/s12889-018-6178-y. doi. Medline.</cite> [<a href="https://doi.org/10.1186/s12889-018-6178-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6234686/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30424761/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Public%20Health&amp;title=The%20effect%20of%20HIV%20educational%20interventions%20on%20HIV-related%20knowledge,%20condom%20use,%20and%20HIV%20incidence%20in%20sub-Saharan%20Africa:%20a%20systematic%20review%20and%20meta-analysis&amp;author=L%20Faust&amp;author=S%20Yaya&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=1254&amp;pmid=30424761&amp;doi=10.1186/s12889-018-6178-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R10">
<span class="label">10.</span><cite>Abdool Karim SS, Baxter C, Abdool Karim Q. Advancing HIV prevention using tenofovir-based pre-exposure prophylaxis. Antivir Ther (Lond) 2022 Apr;27(2) doi: 10.1177/13596535211067589. doi.</cite> [<a href="https://doi.org/10.1177/13596535211067589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35499171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Antivir%20Ther%20(Lond)&amp;title=Advancing%20HIV%20prevention%20using%20tenofovir-based%20pre-exposure%20prophylaxis&amp;author=SS%20Abdool%20Karim&amp;author=C%20Baxter&amp;author=Q%20Abdool%20Karim&amp;volume=27&amp;issue=2&amp;publication_year=2022&amp;pmid=35499171&amp;doi=10.1177/13596535211067589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R11">
<span class="label">11.</span><cite>Ambrosioni J, Petit E, Liegeon G, Laguno M, Miró JM. Primary HIV-1 infection in users of pre-exposure prophylaxis. Lancet HIV. 2021 Mar;8(3):e166–e174. doi: 10.1016/S2352-3018(20)30271-X. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(20)30271-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33316212/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Primary%20HIV-1%20infection%20in%20users%20of%20pre-exposure%20prophylaxis&amp;author=J%20Ambrosioni&amp;author=E%20Petit&amp;author=G%20Liegeon&amp;author=M%20Laguno&amp;author=JM%20Mir%C3%B3&amp;volume=8&amp;issue=3&amp;publication_year=2021&amp;pages=e166-e174&amp;pmid=33316212&amp;doi=10.1016/S2352-3018(20)30271-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R12">
<span class="label">12.</span><cite>Berger RE. Re.: Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. J Urol. 2011 May;185(5):1729–1730. doi: 10.1016/S0022-5347(11)60198-5. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S0022-5347(11)60198-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22088703/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Urol&amp;title=Re.:%20Preexposure%20chemoprophylaxis%20for%20HIV%20prevention%20in%20men%20who%20have%20sex%20with%20men&amp;author=RE%20Berger&amp;volume=185&amp;issue=5&amp;publication_year=2011&amp;pages=1729-1730&amp;pmid=22088703&amp;doi=10.1016/S0022-5347(11)60198-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R13">
<span class="label">13.</span><cite>Ong JJ, Baggaley RC, Wi TE, et al.  Global epidemiologic characteristics of sexually transmitted infections among individuals using preexposure prophylaxis for the prevention of HIV infection: a systematic review and meta-analysis. JAMA Netw Open. 2019 Dec 2;2(12):e1917134.  doi: 10.1001/jamanetworkopen.2019.17134. doi. Medline.</cite> [<a href="https://doi.org/10.1001/jamanetworkopen.2019.17134" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6991203/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31825501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Netw%20Open&amp;title=Global%20epidemiologic%20characteristics%20of%20sexually%20transmitted%20infections%20among%20individuals%20using%20preexposure%20prophylaxis%20for%20the%20prevention%20of%20HIV%20infection:%20a%20systematic%20review%20and%20meta-analysis&amp;author=JJ%20Ong&amp;author=RC%20Baggaley&amp;author=TE%20Wi&amp;volume=2&amp;issue=12&amp;publication_year=2019&amp;pages=e1917134&amp;pmid=31825501&amp;doi=10.1001/jamanetworkopen.2019.17134&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R14">
<span class="label">14.</span><cite>Marrazzo J, Tao L, Becker M, et al.  HIV preexposure prophylaxis with emtricitabine and tenofovir disoproxil fumarate among cisgender women. JAMA. 2024 Mar 19;331(11):930. doi: 10.1001/jama.2024.0464. doi.</cite> [<a href="https://doi.org/10.1001/jama.2024.0464" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10951736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38427359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=HIV%20preexposure%20prophylaxis%20with%20emtricitabine%20and%20tenofovir%20disoproxil%20fumarate%20among%20cisgender%20women&amp;author=J%20Marrazzo&amp;author=L%20Tao&amp;author=M%20Becker&amp;volume=331&amp;issue=11&amp;publication_year=2024&amp;pages=930&amp;pmid=38427359&amp;doi=10.1001/jama.2024.0464&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R15">
<span class="label">15.</span><cite>Molina JM, Ghosn J, Assoumou L, et al.  Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study. Lancet HIV. 2022 Aug;9(8):e554–e562. doi: 10.1016/S2352-3018(22)00133-3. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(22)00133-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35772417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Daily%20and%20on-demand%20HIV%20pre-exposure%20prophylaxis%20with%20emtricitabine%20and%20tenofovir%20disoproxil%20(ANRS%20PREVENIR):%20a%20prospective%20observational%20cohort%20study&amp;author=JM%20Molina&amp;author=J%20Ghosn&amp;author=L%20Assoumou&amp;volume=9&amp;issue=8&amp;publication_year=2022&amp;pages=e554-e562&amp;pmid=35772417&amp;doi=10.1016/S2352-3018(22)00133-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R16">
<span class="label">16.</span><cite>Herrera C, Serwanga J, Else L, et al.  Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial. EBioMedicine. 2023 Jul;93:104648. doi: 10.1016/j.ebiom.2023.104648. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.ebiom.2023.104648" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10275696/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37327677/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EBioMedicine&amp;title=Dose%20finding%20study%20for%20on-demand%20HIV%20pre-exposure%20prophylaxis%20for%20insertive%20sex%20in%20sub-Saharan%20Africa:%20results%20from%20the%20CHAPS%20open%20label%20randomised%20controlled%20trial&amp;author=C%20Herrera&amp;author=J%20Serwanga&amp;author=L%20Else&amp;volume=93&amp;publication_year=2023&amp;pages=104648&amp;pmid=37327677&amp;doi=10.1016/j.ebiom.2023.104648&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R17">
<span class="label">17.</span><cite>Du AB, Head M, Brede M. Integration vs segregation: network analysis of interdisciplinarity in funded and unfunded research on infectious diseases. J Informetr. 2025 Feb;19(1):101634. doi: 10.1016/j.joi.2024.101634. doi.</cite> [<a href="https://doi.org/10.1016/j.joi.2024.101634" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Informetr&amp;title=Integration%20vs%20segregation:%20network%20analysis%20of%20interdisciplinarity%20in%20funded%20and%20unfunded%20research%20on%20infectious%20diseases&amp;author=AB%20Du&amp;author=M%20Head&amp;author=M%20Brede&amp;volume=19&amp;issue=1&amp;publication_year=2025&amp;pages=101634&amp;doi=10.1016/j.joi.2024.101634&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R18">
<span class="label">18.</span><cite>Grulich AE, Guy R, Amin J, et al.  Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018 Nov;5(11):e629–e637. doi: 10.1016/S2352-3018(18)30215-7. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(18)30215-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30343026/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Population-level%20effectiveness%20of%20rapid,%20targeted,%20high-coverage%20roll-out%20of%20HIV%20pre-exposure%20prophylaxis%20in%20men%20who%20have%20sex%20with%20men:%20the%20EPIC-NSW%20prospective%20cohort%20study&amp;author=AE%20Grulich&amp;author=R%20Guy&amp;author=J%20Amin&amp;volume=5&amp;issue=11&amp;publication_year=2018&amp;pages=e629-e637&amp;pmid=30343026&amp;doi=10.1016/S2352-3018(18)30215-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R19">
<span class="label">19.</span><cite>Bórquez A, Guanira JV, Revill P, et al.  The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study. Lancet Public Health. 2019 Mar;4(3):e127–e136. doi: 10.1016/S2468-2667(18)30236-6. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2468-2667(18)30236-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6447307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30683587/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Public%20Health&amp;title=The%20impact%20and%20cost-effectiveness%20of%20combined%20HIV%20prevention%20scenarios%20among%20transgender%20women%20sex-workers%20in%20Lima,%20Peru:%20a%20mathematical%20modelling%20study&amp;author=A%20B%C3%B3rquez&amp;author=JV%20Guanira&amp;author=P%20Revill&amp;volume=4&amp;issue=3&amp;publication_year=2019&amp;pages=e127-e136&amp;pmid=30683587&amp;doi=10.1016/S2468-2667(18)30236-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R20">
<span class="label">20.</span><cite>Wu L, Kaftan D, Wittenauer R, et al.  Health impact, budget impact, and price threshold for cost-effectiveness of lenacapavir for HIV pre-exposure prophylaxis in eastern and southern Africa: a modelling analysis. Lancet HIV. 2024 Nov;11(11):e765–e773. doi: 10.1016/S2352-3018(24)00239-X. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(24)00239-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11519315/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39312933/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Health%20impact,%20budget%20impact,%20and%20price%20threshold%20for%20cost-effectiveness%20of%20lenacapavir%20for%20HIV%20pre-exposure%20prophylaxis%20in%20eastern%20and%20southern%20Africa:%20a%20modelling%20analysis&amp;author=L%20Wu&amp;author=D%20Kaftan&amp;author=R%20Wittenauer&amp;volume=11&amp;issue=11&amp;publication_year=2024&amp;pages=e765-e773&amp;pmid=39312933&amp;doi=10.1016/S2352-3018(24)00239-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R21">
<span class="label">21.</span><cite>Desai M, Field N, Grant R, McCormack S. Recent advances in pre-exposure prophylaxis for HIV. BMJ. 2017 Dec 11;359:j5011.  doi: 10.1136/bmj.j5011. doi. Medline.</cite> [<a href="https://doi.org/10.1136/bmj.j5011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6020995/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29229609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Recent%20advances%20in%20pre-exposure%20prophylaxis%20for%20HIV&amp;author=M%20Desai&amp;author=N%20Field&amp;author=R%20Grant&amp;author=S%20McCormack&amp;volume=359&amp;publication_year=2017&amp;pages=j5011&amp;pmid=29229609&amp;doi=10.1136/bmj.j5011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R22">
<span class="label">22.</span><cite>Ngure K, Ortblad KF, Mogere P, et al.  Efficiency of 6-month PrEP dispensing with HIV self-testing in Kenya: an open-label, randomised, non-inferiority, implementation trial. Lancet HIV. 2022 Jul;9(7):e464–e473. doi: 10.1016/S2352-3018(22)00126-6. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(22)00126-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10348060/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35777410/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Efficiency%20of%206-month%20PrEP%20dispensing%20with%20HIV%20self-testing%20in%20Kenya:%20an%20open-label,%20randomised,%20non-inferiority,%20implementation%20trial&amp;author=K%20Ngure&amp;author=KF%20Ortblad&amp;author=P%20Mogere&amp;volume=9&amp;issue=7&amp;publication_year=2022&amp;pages=e464-e473&amp;pmid=35777410&amp;doi=10.1016/S2352-3018(22)00126-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R23">
<span class="label">23.</span><cite>Kearney BP, Flaherty JF, Shah J. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics. Clin Pharmacokinet. 2004;43(9):595–612. doi: 10.2165/00003088-200443090-00003. doi. Medline.</cite> [<a href="https://doi.org/10.2165/00003088-200443090-00003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15217303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacokinet&amp;title=Tenofovir%20disoproxil%20fumarate:%20clinical%20pharmacology%20and%20pharmacokinetics&amp;author=BP%20Kearney&amp;author=JF%20Flaherty&amp;author=J%20Shah&amp;volume=43&amp;issue=9&amp;publication_year=2004&amp;pages=595-612&amp;pmid=15217303&amp;doi=10.2165/00003088-200443090-00003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R24">
<span class="label">24.</span><cite>Wu B, Shen JF, Cheng HF. Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China. BMC Health Serv Res. 2012 Nov 8;12:12. doi: 10.1186/1472-6963-12-385. doi. Medline.</cite> [<a href="https://doi.org/10.1186/1472-6963-12-385" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3511237/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23137013/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Health%20Serv%20Res&amp;title=Cost-effectiveness%20analysis%20of%20different%20rescue%20therapies%20in%20patients%20with%20lamivudine-resistant%20chronic%20hepatitis%20B%20in%20China&amp;author=B%20Wu&amp;author=JF%20Shen&amp;author=HF%20Cheng&amp;volume=12&amp;publication_year=2012&amp;pages=12&amp;pmid=23137013&amp;doi=10.1186/1472-6963-12-385&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R25">
<span class="label">25.</span><cite>Pampati S, Emrick K, Siegler AJ, Jones J. Changes in sexual behavior, PrEP adherence, and access to sexual health services because of the COVID-19 pandemic among a cohort of PrEP-using MSM in the South. J Acquir Immune Defic Syndr. 2021 May 1;87(1):639–643. doi: 10.1097/QAI.0000000000002640. doi. Medline.</cite> [<a href="https://doi.org/10.1097/QAI.0000000000002640" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8533029/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33512848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Acquir%20Immune%20Defic%20Syndr&amp;title=Changes%20in%20sexual%20behavior,%20PrEP%20adherence,%20and%20access%20to%20sexual%20health%20services%20because%20of%20the%20COVID-19%20pandemic%20among%20a%20cohort%20of%20PrEP-using%20MSM%20in%20the%20South&amp;author=S%20Pampati&amp;author=K%20Emrick&amp;author=AJ%20Siegler&amp;author=J%20Jones&amp;volume=87&amp;issue=1&amp;publication_year=2021&amp;pages=639-643&amp;pmid=33512848&amp;doi=10.1097/QAI.0000000000002640&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R26">
<span class="label">26.</span><cite>Molina JM, Capitant C, Spire B, et al.  On-Demand preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015 Dec 3;373(23):2237–2246. doi: 10.1056/NEJMoa1506273. doi. Medline.</cite> [<a href="https://doi.org/10.1056/NEJMoa1506273" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26624850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=On-Demand%20preexposure%20prophylaxis%20in%20men%20at%20high%20risk%20for%20HIV-1%20infection&amp;author=JM%20Molina&amp;author=C%20Capitant&amp;author=B%20Spire&amp;volume=373&amp;issue=23&amp;publication_year=2015&amp;pages=2237-2246&amp;pmid=26624850&amp;doi=10.1056/NEJMoa1506273&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R27">
<span class="label">27.</span><cite>Liu AY, Cohen SE, Vittinghoff E, et al.  Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016 Jan;176(1):75–84. doi: 10.1001/jamainternmed.2015.4683. doi. Medline.</cite> [<a href="https://doi.org/10.1001/jamainternmed.2015.4683" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5042323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26571482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Intern%20Med&amp;title=Preexposure%20prophylaxis%20for%20HIV%20infection%20integrated%20with%20municipal-%20and%20community-based%20sexual%20health%20services&amp;author=AY%20Liu&amp;author=SE%20Cohen&amp;author=E%20Vittinghoff&amp;volume=176&amp;issue=1&amp;publication_year=2016&amp;pages=75-84&amp;pmid=26571482&amp;doi=10.1001/jamainternmed.2015.4683&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R28">
<span class="label">28.</span><cite>Grulich AE, Jin F, Bavinton BR, et al.  Long-term protection from HIV infection with oral HIV pre-exposure prophylaxis in gay and bisexual men: findings from the expanded and extended EPIC-NSW prospective implementation study. Lancet HIV. 2021 Aug;8(8):e486–e494. doi: 10.1016/S2352-3018(21)00074-6. doi. Medline.</cite> [<a href="https://doi.org/10.1016/S2352-3018(21)00074-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34217426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20HIV&amp;title=Long-term%20protection%20from%20HIV%20infection%20with%20oral%20HIV%20pre-exposure%20prophylaxis%20in%20gay%20and%20bisexual%20men:%20findings%20from%20the%20expanded%20and%20extended%20EPIC-NSW%20prospective%20implementation%20study&amp;author=AE%20Grulich&amp;author=F%20Jin&amp;author=BR%20Bavinton&amp;volume=8&amp;issue=8&amp;publication_year=2021&amp;pages=e486-e494&amp;pmid=34217426&amp;doi=10.1016/S2352-3018(21)00074-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R29">
<span class="label">29.</span><cite>Wahome EW, Graham SM, Thiong’o AN, et al.  PrEP uptake and adherence in relation to HIV-1 incidence among Kenyan men who have sex with men. EClinicalMedicine. 2020 Sep;26:100541. doi: 10.1016/j.eclinm.2020.100541. doi. Medline.</cite> [<a href="https://doi.org/10.1016/j.eclinm.2020.100541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7565200/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33089128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EClinicalMedicine&amp;title=PrEP%20uptake%20and%20adherence%20in%20relation%20to%20HIV-1%20incidence%20among%20Kenyan%20men%20who%20have%20sex%20with%20men&amp;author=EW%20Wahome&amp;author=SM%20Graham&amp;author=AN%20Thiong%E2%80%99o&amp;volume=26&amp;publication_year=2020&amp;pages=100541&amp;pmid=33089128&amp;doi=10.1016/j.eclinm.2020.100541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R30">
<span class="label">30.</span><cite>Rodger AJ, Cambiano V, Bruun T, et al.  Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the hiv-positive partner is using suppressive antiretroviral therapy. JAMA. 2016 Jul 12;316(2):171–181. doi: 10.1001/jama.2016.5148. doi. Medline.</cite> [<a href="https://doi.org/10.1001/jama.2016.5148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27404185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Sexual%20activity%20without%20condoms%20and%20risk%20of%20HIV%20transmission%20in%20serodifferent%20couples%20when%20the%20hiv-positive%20partner%20is%20using%20suppressive%20antiretroviral%20therapy&amp;author=AJ%20Rodger&amp;author=V%20Cambiano&amp;author=T%20Bruun&amp;volume=316&amp;issue=2&amp;publication_year=2016&amp;pages=171-181&amp;pmid=27404185&amp;doi=10.1001/jama.2016.5148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R31">
<span class="label">31.</span><cite>Traeger MW, Schroeder SE, Wright EJ, et al.  Effects of pre-exposure prophylaxis for the prevention of Human Immunodeficiency Virus infection on sexual risk behavior in men who have sex with men: a systematic review and meta-analysis. Clin Infect Dis. 2018 Aug 16;67(5):676–686. doi: 10.1093/cid/ciy182. doi. Medline.</cite> [<a href="https://doi.org/10.1093/cid/ciy182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29509889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Infect%20Dis&amp;title=Effects%20of%20pre-exposure%20prophylaxis%20for%20the%20prevention%20of%20Human%20Immunodeficiency%20Virus%20infection%20on%20sexual%20risk%20behavior%20in%20men%20who%20have%20sex%20with%20men:%20a%20systematic%20review%20and%20meta-analysis&amp;author=MW%20Traeger&amp;author=SE%20Schroeder&amp;author=EJ%20Wright&amp;volume=67&amp;issue=5&amp;publication_year=2018&amp;pages=676-686&amp;pmid=29509889&amp;doi=10.1093/cid/ciy182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R32">
<span class="label">32.</span><cite>Spees LP, Wirth KE, Mawandia S, Bazghina-Werq S, Ledikwe JH. Sexual risk compensation following voluntary medical male circumcision: results from a prospective cohort study amongst human immunodeficiency virus-negative adult men in Botswana. South Afr J HIV Med. 2020;21(1):1157.  doi: 10.4102/sajhivmed.v21i1.1157. doi. Medline.</cite> [<a href="https://doi.org/10.4102/sajhivmed.v21i1.1157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7756904/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33391832/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=South%20Afr%20J%20HIV%20Med&amp;title=Sexual%20risk%20compensation%20following%20voluntary%20medical%20male%20circumcision:%20results%20from%20a%20prospective%20cohort%20study%20amongst%20human%20immunodeficiency%20virus-negative%20adult%20men%20in%20Botswana&amp;author=LP%20Spees&amp;author=KE%20Wirth&amp;author=S%20Mawandia&amp;author=S%20Bazghina-Werq&amp;author=JH%20Ledikwe&amp;volume=21&amp;issue=1&amp;publication_year=2020&amp;pages=1157&amp;pmid=33391832&amp;doi=10.4102/sajhivmed.v21i1.1157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R33">
<span class="label">33.</span><cite>van de Vijver DAMC, Nichols BE, Abbas UL, et al.  Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS. 2013 Nov 28;27(18):2943–2951. doi: 10.1097/01.aids.0000433237.63560.20. doi. Medline.</cite> [<a href="https://doi.org/10.1097/01.aids.0000433237.63560.20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23939237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=AIDS&amp;title=Preexposure%20prophylaxis%20will%20have%20a%20limited%20impact%20on%20HIV-1%20drug%20resistance%20in%20sub-Saharan%20Africa:%20a%20comparison%20of%20mathematical%20models&amp;author=DAMC%20van%20de%20Vijver&amp;author=BE%20Nichols&amp;author=UL%20Abbas&amp;volume=27&amp;issue=18&amp;publication_year=2013&amp;pages=2943-2951&amp;pmid=23939237&amp;doi=10.1097/01.aids.0000433237.63560.20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R34">
<span class="label">34.</span><cite>Goldwirt L, Bauer R, Liegeon G, et al.  Estimated pill intake with on-demand PrEP with oral TDF/FTC using TFV-DP concentration in dried blood spots in the ANRS IPERGAY trial. J Antimicrob Chemother. 2021 Sep 15;76(10):2675–2680. doi: 10.1093/jac/dkab253. doi. Medline.</cite> [<a href="https://doi.org/10.1093/jac/dkab253" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34278433/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Antimicrob%20Chemother&amp;title=Estimated%20pill%20intake%20with%20on-demand%20PrEP%20with%20oral%20TDF/FTC%20using%20TFV-DP%20concentration%20in%20dried%20blood%20spots%20in%20the%20ANRS%20IPERGAY%20trial&amp;author=L%20Goldwirt&amp;author=R%20Bauer&amp;author=G%20Liegeon&amp;volume=76&amp;issue=10&amp;publication_year=2021&amp;pages=2675-2680&amp;pmid=34278433&amp;doi=10.1093/jac/dkab253&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="R35">
<span class="label">35.</span><cite>Dong MJ, Peng B, Liu ZF, et al.  The prevalence of HIV among MSM in China: a large-scale systematic analysis. BMC Infect Dis. 2019 Nov 27;19(1):1000.  doi: 10.1186/s12879-019-4559-1. doi. Medline.</cite> [<a href="https://doi.org/10.1186/s12879-019-4559-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6880607/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31775654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Infect%20Dis&amp;title=The%20prevalence%20of%20HIV%20among%20MSM%20in%20China:%20a%20large-scale%20systematic%20analysis&amp;author=MJ%20Dong&amp;author=B%20Peng&amp;author=ZF%20Liu&amp;volume=19&amp;issue=1&amp;publication_year=2019&amp;pages=1000&amp;pmid=31775654&amp;doi=10.1186/s12879-019-4559-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Multimedia Appendix 1. Study questionnaire.</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12367284/bin/publichealth-v11-e71494-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">publichealth-v11-e71494-s001.docx</a><sup> (80KB, docx) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71494</div>
</div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><span>Checklist 1. CONSORT checklist.</span></div>
<div class="media p">
<div class="caption">
<a href="/articles/instance/12367284/bin/publichealth-v11-e71494-s002.pdf" data-ga-action="click_feat_suppl" class="usa-link">publichealth-v11-e71494-s002.pdf</a><sup> (214.1KB, pdf) </sup>
</div>
<div class="object-id font-xs text-base-dark">DOI: 10.2196/71494</div>
</div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from JMIR Public Health and Surveillance are provided here courtesy of <strong>JMIR Publications Inc.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.2196/71494"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12367284/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12367284/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12367284%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12367284/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12367284/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12367284/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40834420/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12367284/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40834420/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12367284/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12367284/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6PnpzgcoukQndT0U2RmDf0J60edc2keDe7rxWUC5tlPX7Oyrf31eKxqQ9jYniI5b">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
